[1]
A. Inan El-Naggar, A. Karakatsanis, and A. Valachis, “Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based study”, AO, vol. 64, pp. 1334–1341, Oct. 2025.